Oral esketamine in patients with treatment-resistant depression: a double-blind, randomized, placebo-controlled trial with open-label extension.

Journal: Molecular psychiatry

Publication Year: 

Authors & Co-authors:  Smith-Apeldoorn Veraart Kamphuis Spijker van der Meij van Asselt Aan Het Rot Schoevers